University of California, San Francisco, United States
Apeximmune (Ownership Interest includes stock, stock options, patent or other intellectual property)Aria Pharmaceuticals (Consultant/Advisory Board)Exagen (Consultant/Advisory Board)Pfizer (Ownership Interest includes stock, stock options, patent or other intellectual property)Somnics (Ownership Interest includes stock, stock options, patent or other intellectual property)TallacTx (Consultant/Advisory Board)
Friday, August 26, 2022
1:30 PM – 1:45 PM CEST